Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $1.62 billion. The enterprise value is $1.54 billion.
Important Dates
The last earnings date was Tuesday, May 6, 2025, after market close.
| Earnings Date | May 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 119.20 million shares outstanding. The number of shares has increased by 52.50% in one year.
| Current Share Class | 119.20M |
| Shares Outstanding | 119.20M |
| Shares Change (YoY) | +52.50% |
| Shares Change (QoQ) | +0.90% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 83.54% |
| Float | 85.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7.99 |
| Forward PS | 6.68 |
| PB Ratio | 11.38 |
| P/TBV Ratio | 12.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.55, with a Debt / Equity ratio of 0.78.
| Current Ratio | 3.55 |
| Quick Ratio | 3.11 |
| Debt / Equity | 0.78 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -5.35 |
Financial Efficiency
Return on equity (ROE) is -70.58% and return on invested capital (ROIC) is -22.13%.
| Return on Equity (ROE) | -70.58% |
| Return on Assets (ROA) | -18.43% |
| Return on Invested Capital (ROIC) | -22.13% |
| Return on Capital Employed (ROCE) | -47.95% |
| Revenue Per Employee | $622,278 |
| Profits Per Employee | -$379,289 |
| Employee Count | 342 |
| Asset Turnover | 0.52 |
| Inventory Turnover | 1.65 |
Taxes
In the past 12 months, ARQT has paid $602,000 in taxes.
| Income Tax | 602,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +67.65% in the last 52 weeks. The beta is 1.87, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.87 |
| 52-Week Price Change | +67.65% |
| 50-Day Moving Average | 14.77 |
| 200-Day Moving Average | 12.15 |
| Relative Strength Index (RSI) | 44.68 |
| Average Volume (20 Days) | 2,011,358 |
Short Selling Information
The latest short interest is 15.14 million, so 12.70% of the outstanding shares have been sold short.
| Short Interest | 15.14M |
| Short Previous Month | 14.38M |
| Short % of Shares Out | 12.70% |
| Short % of Float | 17.62% |
| Short Ratio (days to cover) | 6.38 |
Income Statement
In the last 12 months, ARQT had revenue of $212.82 million and -$129.72 million in losses. Loss per share was -$1.04.
| Revenue | 212.82M |
| Gross Profit | 188.12M |
| Operating Income | -121.30M |
| Pretax Income | -214.05M |
| Net Income | -129.72M |
| EBITDA | -115.93M |
| EBIT | -121.30M |
| Loss Per Share | -$1.04 |
Full Income StatementBalance Sheet
The company has $198.09 million in cash and $110.80 million in debt, giving a net cash position of $87.29 million or $0.73 per share.
| Cash & Cash Equivalents | 198.09M |
| Total Debt | 110.80M |
| Net Cash | 87.29M |
| Net Cash Per Share | $0.73 |
| Equity (Book Value) | 142.66M |
| Book Value Per Share | 1.20 |
| Working Capital | 232.54M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$110.94 million and capital expenditures -$751,000, giving a free cash flow of -$111.69 million.
| Operating Cash Flow | -110.94M |
| Capital Expenditures | -751,000 |
| Free Cash Flow | -111.69M |
| FCF Per Share | -$0.94 |
Full Cash Flow StatementMargins
Gross margin is 88.39%, with operating and profit margins of -57.00% and -60.95%.
| Gross Margin | 88.39% |
| Operating Margin | -57.00% |
| Pretax Margin | -60.67% |
| Profit Margin | -60.95% |
| EBITDA Margin | -54.47% |
| EBIT Margin | -57.00% |
| FCF Margin | n/a |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -52.50% |
| Shareholder Yield | -52.50% |
| Earnings Yield | -7.98% |
| FCF Yield | -6.87% |
Analyst Forecast
The average price target for ARQT is $18.80, which is 37.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.80 |
| Price Target Difference | 37.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 34.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of -0.59 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.59 |
| Piotroski F-Score | 3 |